Bio-Rad Laboratories (BIO-B) FCF Margin Growth (3y) (2012 - 2026)
Bio-Rad Laboratories (BIO-B) FCF Margin Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 38.00 |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 30.00 |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 943.00 |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 96.00 |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -2,196.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -20.00 |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 2,679.00 |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -461.00 |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 417.00 |
| 10 | Bio-Rad Laboratories | - | - | 309.40 Mn | 397.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 397.00 |
| Dec 31, 2025 | 1,105.00 |
| Sep 30, 2025 | 1,610.00 |
| Jun 30, 2025 | 566.00 |
| Mar 31, 2025 | 1,383.00 |
| Dec 31, 2024 | -348.00 |
| Sep 30, 2024 | -721.00 |
| Jun 30, 2024 | -967.00 |
| Mar 31, 2024 | -810.00 |
| Dec 31, 2023 | -2,540.00 |
| Sep 30, 2023 | -939.00 |
| Jun 30, 2023 | -447.00 |
| Mar 31, 2023 | 201.00 |
| Dec 31, 2022 | -1,600.00 |
| Sep 30, 2022 | -1,469.00 |
| Jun 30, 2022 | -1,806.00 |
| Mar 31, 2022 | -99.00 |
| Dec 31, 2021 | 1,968.00 |
| Sep 30, 2021 | 1,478.00 |
| Jun 30, 2021 | 9.00 |